9295 related articles for article (PubMed ID: 10363176)
1. A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene.
Cao G; Zhang X; He X; Chen Q; Qi Z
In Vivo; 1999; 13(2):181-7. PubMed ID: 10363176
[TBL] [Abstract][Full Text] [Related]
2. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ
Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187
[TBL] [Abstract][Full Text] [Related]
3. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts.
Gabius HJ; Darro F; Remmelink M; André S; Kopitz J; Danguy A; Gabius S; Salmon I; Kiss R
Cancer Invest; 2001; 19(2):114-26. PubMed ID: 11296616
[TBL] [Abstract][Full Text] [Related]
4. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
Marchetti D; Nicolson GL
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
[TBL] [Abstract][Full Text] [Related]
5. [Experimental research to clinical application of interferons].
Imamishi J; Tanaka A
Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
[TBL] [Abstract][Full Text] [Related]
6. Trichinella spiralis as a modulator of Shope fibroma virus.
Bellelli C; Frosi A; Chiovoloni M; Grelloni V; Baldelli B
Parassitologia; 1989; 31(2-3):145-52. PubMed ID: 2562107
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?
Patel S; Kostaras X; Parliament M; Olivotto IA; Nordal R; Aronyk K; Hagen N
Curr Oncol; 2014 Oct; 21(5):251-62. PubMed ID: 25302033
[TBL] [Abstract][Full Text] [Related]
8. [Screening of cytotoxic activity against B16 tumor cell of mangrove fungi isolate from Qinglan harbor in Hainan].
Miao C; Zhuang L; Lin H; Hong K
Sheng Wu Gong Cheng Xue Bao; 2008 Jun; 24(6):975-9. PubMed ID: 18807979
[TBL] [Abstract][Full Text] [Related]
9. Cystemustine INSERM.
Palmer B
IDrugs; 1998 May; 1(1):129-35. PubMed ID: 18465517
[TBL] [Abstract][Full Text] [Related]
10. [Congenital melanocytic nevi--a multifaceted problem].
Hamm H
MMW Fortschr Med; 2007 Feb; 149(6):33-5. PubMed ID: 17619400
[TBL] [Abstract][Full Text] [Related]
11. Patient with double cancer--successfully treated.
Djukić VB; Kastratović DA; Pendjer IP; Majstorović BM; Nikolić LjI; Boricić IV; Vujicić ZN
Acta Chir Iugosl; 2005; 52(3):91-3. PubMed ID: 16813002
[TBL] [Abstract][Full Text] [Related]
12. SIAscopy--a new non-invasive technique of melanoma diagnosis.
Michalska M; Chodorowska G; Krasowska D
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):421-31. PubMed ID: 16146122
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations.
Almahroos M; Kurban AK
Skinmed; 2004; 3(3):132-9. PubMed ID: 15133392
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
15. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls.
Morton CA
J Dermatolog Treat; 2003; 14 Suppl 3():23-6. PubMed ID: 14522638
[TBL] [Abstract][Full Text] [Related]
16. Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.
Kondo H; Sahara H; Miyazaki A; Nabeta Y; Hirohashi Y; Kanaseki T; Yamaguchi A; Yamada N; Hirayama K; Suzuki M; Hamuro J; Torigoe T; Takahashi N; Kohama GI; Ikeda H; Sato N
Jpn J Cancer Res; 2002 Aug; 93(8):917-24. PubMed ID: 12716470
[TBL] [Abstract][Full Text] [Related]
17. CD40 activation as potential tool in malignant neoplasms.
Ottaiano A; Pisano C; De Chiara A; Ascierto PA; Botti G; Barletta E; Apice G; Gridelli C; Iaffaioli VR
Tumori; 2002; 88(5):361-6. PubMed ID: 12487551
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in vaccination therapies of malignant diseases.
Brossart P
Transfus Apher Sci; 2002 Oct; 27(2):183-6. PubMed ID: 12350054
[TBL] [Abstract][Full Text] [Related]
19. Mutant laboratory mice with abnormalities in pigmentation: annotated tables.
Nakamura M; Tobin DJ; Richards-Smith B; Sundberg JP; Paus R
J Dermatol Sci; 2002 Jan; 28(1):1-33. PubMed ID: 11916127
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-effect biomarkers in prevention of skin cancer.
Doré JF; Pedeux R; Boniol M; Chignol MC; Autier P
IARC Sci Publ; 2001; 154():81-91. PubMed ID: 11220671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
